Identifying the causative agent of infection before initiating antimicrobial therapy is crucial. This step facilitates the selection of appropriate antimicrobial agents, enhances treatment efficacy, and minimizes unnecessary drug utilization.
Utilization of antimicrobial drugs should adhere to the principles of rational drug use, encompassing appropriate drug selection, dosage, route, timing, and duration of administration. To prevent the development of bacterial resistance, it is essential to avoid overuse or inappropriate use of antimicrobials.
Patients in the infectious disease department may be taking multiple drugs at the same time, so drug interactions need to be noted.
In particular, interactions between antimicrobials and other drugs may affect the efficacy of drugs or increase the risk of adverse effects.
Adherence to antimicrobial utilization guidelines is crucial, including considerations such as oral administration preference over intramuscular injection and intramuscular injection preference over infusion.
Discretion in avoiding unnecessary intravenous fluids can mitigate infection risks and enhance patient comfort.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1572025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1552025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1702024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1602024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1452024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2472024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: